In vitro effect of malachite green on Candida albicans involves multiple pathways and transcriptional regulators UPC2 and STP2

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 1, 2012, Pages 495-506

  Dhamgaye, Sanjiveeni ^a   Devaux, Frederic ^b,e   Manoharlal, Raman ^a,f   Vandeputte, Patrick ^d   Shah, Abdul Haseeb ^a   Singh, Ashutosh ^a   Blugeon, Corinne ^c   Sanglard, Dominique ^d   Prasad, Rajendra ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b ECOLE NORMALE SUPÉRIEURE   (France)

^c PSL RESEARCH UNIVERSITY   (France)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e Campus des Cordeliers   (France)

^f UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOSTEROL; IRON; MALACHITE GREEN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR QRD1; TRANSCRIPTION FACTOR STP2; TRANSCRIPTION FACTOR UPC2; TRANSCRIPTOME; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DOWN REGULATION; FUNGAL CELL; FUNGAL GENE; FUNGAL VIRULENCE; FUNGUS GROWTH; HEAT SHOCK; MINIMUM INHIBITORY CONCENTRATION; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; STEROL METABOLISM; UPREGULATION;

AMINO ACID TRANSPORT SYSTEMS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; ERGOSTEROL; FERMENTATION; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; IRON; MICROBIAL SENSITIVITY TESTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REACTIVE OXYGEN SPECIES; ROSANILINE DYES; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTOME;

EID: 84455192724     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00574-11     Document Type: Article

References (53)

1. Askew C, et al. 2009. Transcriptional regulation of carbohydrate metabolism in the human pathogen Candida albicans. PLoS Pathog. 5:e1000612.
2. Banerjee D, et al. 2008. Responses of pathogenic and nonpathogenic yeast species to steroids reveal the functioning and evolution of multidrug resistance transcriptional networks. Eukaryot. Cell 7:68-77. (Pubitemid 351959595)
3. Bonhomme J, et al. 2011. Contribution of the glycolytic flux and hypoxia adaptation to efficient biofilm formation by Candida albicans. Mol. Microbiol. 80:995-1013.
4. Boyle EI, et al. 2004. GO::TermFinder - open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. Bioinformatics 20:3710-3715. (Pubitemid 40136825)
5. Bragulat MR, Abarca ML, Castella G, Cabanes FJ. 1995. Dyes as fungal inhibitors: effect on colony enumeration. J. Appl. Bacteriol. 79:578-582.
6. Cabiscol E, et al. 2002. Mitochondrial Hsp60, resistance to oxidative stress, and the labile iron pool are closely connected in Saccharomyces cerevisiae. J. Biol. Chem. 277:44531-44538. (Pubitemid 36157888)
7. Clemmensen S, et al. 1984. Toxicological studies on malachite green: a triphenylmethane dye. Arch. Toxicol. 56:43-45. (Pubitemid 15186320)
8. Clinical and Laboratory Standards Institute (CLSI). 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard -3rd ed. CLSI document M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Culp SJ, et al. 1999. Toxicity and metabolism of malachite green and leucomalachite green during short-term feeding to Fischer 344 rats and B6C3F1 mice. Chem. Biol. Interact. 122:153-170. (Pubitemid 29421775)
10. Culp SJ, et al. 2002. Mutagenicity and carcinogenicity in relation to DNA adduct formation in rats fed leucomalachite green. Mutat. Res. 506-507:55-63. (Pubitemid 35286540)
11. Davis DA, Bruno VM, Loza L, Filler SG, Mitchell AP. 2002. Candida albicans Mds3p, a conserved regulator of pH responses and virulence identified through insertional mutagenesis. Genetics 162:1573-1581. (Pubitemid 36114647)
12. Decottignies A, et al. 1998. ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J. Biol. Chem. 273:12612-12622. (Pubitemid 28240639)
13. Eisenberg T, Carmona-Gutierrez D, Buttner S, Tavernarakis N, Madeo F. 2010. Necrosis in yeast. Apoptosis 15:257-268.
14. Epsztejn S, Kakhlon O, Glickstein H, Breuer W, Cabantchik I. 1997. Fluorescence analysis of the labile iron pool of mammalian cells. Anal. Biochem. 248:31-40. (Pubitemid 27218221)
15. Fardeau V, et al. 2007. The central role of PDR1 in the foundation of yeast drug resistance. J. Biol. Chem. 282:5063-5074. (Pubitemid 47100939)
16. Fonzi WA, Irwin MY. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728. (Pubitemid 23193572)
17. Franz R, et al. 1998. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob. Agents Chemother. 42:3065-3072. (Pubitemid 28553719)
18. Franz R, Ruhnke M, Morschhauser J. 1999. Molecular aspects of fluconazole resistance development in Candida albicans. Mycoses 42:453-458. (Pubitemid 29470386)
19. Gasch AP, et al. 2001. Genomic expression responses to DNA-damaging agents and the regulatory role of the yeastATRhomolog Mec1p. Mol. Biol. Cell 12:2987-3003. (Pubitemid 33062956)
20. Gola S, Martin R, Walther A, Dunkler A, Wendland J. 2003. New modules for PCR-based gene targeting in Candida albicans: rapid and efficient gene targeting using 100 bp of flanking homology region. Yeast 20:1339-1347. (Pubitemid 38016628)
21. Hameed S, Dhamgaye S, Singh A, Goswami SK, Prasad R. 2011. Calcineurin signaling and membrane lipid homeostasis regulates iron mediated multidrug resistance mechanisms in Candida albicans. Plos One. 6:e18684. doi:10.1371/journal.pone.0018684.
22. Jiao B, Yeung EK, Chan CB, Cheng CH. 2008. Establishment of a transgenic yeast screening system for estrogenicity and identification of the anti-estrogenic activity of malachite green. J. Cell. Biochem. 105:1399-1409.
23. Kohli A, Smriti Mukhopadhyay K, Rattan A, Prasad R. 2002. In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry. Antimicrob. Agents Chemother. 46:1046-1052. (Pubitemid 34260349)
24. Lamping E, et al. 2007. Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae. Eukaryot. Cell 6:1150-1165. (Pubitemid 47077167)
25. Landolfo S, Politi H, Angelozzi D, Mannazzu I. 2008. ROS accumulation and oxidative damage to cell structures in Saccharomyces cerevisiae wine strains during fermentation of high-sugar-containing medium. Biochim. Biophys. Acta 1780:892-898.
26. Lemoine S, Combes F, Servant N, Le Crom S. 2006. Goulphar: rapid access and expertise for standard two-color microarray normalization methods. BMC Bioinformatics 7:467.
27. Martins CV, et al. 2009. Curcumin as a promising antifungal of clinical interest. J. Antimicrob. Chemother. 63:337-339.
28. McCluskey K, Wiest A, Plamann M. 2010. The Fungal Genetics Stock Center: a repository for 50 years of fungal genetics research. J. Biosci. 35:119-126.
29. Menezes RA, et al. 2008. Contribution of Yap1 towards Saccharomyces cerevisiae adaptation to arsenic-mediated oxidative stress. Biochem. J. 414:301-311.
30. Morschhauser J. 2010. Regulation of white-opaque switching in Candida albicans. Med. Microbiol. Immunol. 199:165-172.
31. Morschhauser J, Michel S, Staib P. 1999. Sequential gene disruption in Candida albicans by FLP-mediated site-specific recombination. Mol. Microbiol. 32:547-556. (Pubitemid 29233899)
32. Mukhopadhyay K, Kohli AK, Prasad R. 2002. Drug susceptibilities of yeast cells are affected by membrane lipid composition. Antimicrob. Agents Chemother. 46:3695-3705. (Pubitemid 35403239)
33. Mukhopadhyay K, et al. 2004. Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans. Antimicrob. Agents Chemother. 48:1778-1787. (Pubitemid 38544389)
34. Nunes PA, Tenreiro S, Sa-Correia I. 2001. Resistance and adaptation to quinidine in Saccharomyces cerevisiae: role of QDR1 (YIL120w), encoding a plasma membrane transporter of the major facilitator superfamily required for multidrug resistance. Antimicrob. Agents Chemother. 45:1528-1534. (Pubitemid 32374129)
35. Odds FC, Brown AJ, Gow NA. 2003. Antifungal agents: mechanisms of action. Trends Microbiol. 11:272-279. (Pubitemid 36725017)
36. Prasad R, Kapoor K. 2005. Multidrug resistance in yeast Candida. Int. Rev. Cytol. 242:215-248. (Pubitemid 39642964)
37. Reuss O, Vik A, Kolter R, Morschhauser J. 2004. The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341:119-127. (Pubitemid 39335889)
38. Saeed AI, et al. 2006. TM4 microarray software suite. Methods Enzymol. 411:134-193.
39. Saeed AI, et al. 2003. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34:374-378. (Pubitemid 36184095)
40. Serra A, Strehaiano P, Taillandier P. 2003. Characterization of the metabolic shift of Saccharomyces bayanus var. uvarum by continuous aerobic culture. Appl. Microbiol. Biotechnol. 62:564-568. (Pubitemid 37372452)
41. Sharma M, Manoharlal R, Puri N, Prasad R. 2010. Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans. Biosci. Rep. 30:391-404.
42. Shukla S, Saini P, Smriti Jha S, Ambudkar SV, Prasad R. 2003. Functional characterization of Candida albicans ABC transporter Cdr1p. Eukaryot. Cell 2:1361-1375. (Pubitemid 38047243)
43. Souza RC, et al. 2010. Comparison of the photodynamic fungicidal efficacy of methylene blue, toluidine blue, malachite green and low-power laser irradiation alone against Candida albicans. Lasers Med. Sci. 25:385-389.
44. Srivastava S, Sinha R, Roy D. 2004. Toxicological effects of malachite green. Aquat. Toxicol. 66:319-329. (Pubitemid 38201237)
45. Tsao S, Rahkhoodaee F, Raymond M. 2009. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance. Antimicrob. Agents Chemother. 53:1344-1352.
46. Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98:5116-5121. (Pubitemid 32397092)
47. Wang X, et al. 2009. Effect of berberine on Staphylococcus epidermidis biofilm formation. Int. J. Antimicrob. Agents 34:60-66.
48. White TC, Holleman S, Dy F, Mirels LF, Stevens DA. 2002. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob. Agents Chemother. 46:1704-1713. (Pubitemid 34535186)
49. Wilson RB, Davis D, Mitchell AP. 1999. Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions. J. Bacteriol. 181:1868-1874. (Pubitemid 29138620)
50. Xu RH, et al. 2005. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 65:613-621.
51. Ying S, Qing S, Chunyang L. 2010. The effect of gentian violet on virulent properties of Candida albicans. Mycopathologia 169:279-285.
52. Zhang H, et al. 2009. Mechanism of action of tetrandrine, a natural inhibitor of Candida albicans drug efflux pumps. Yakugaku Zasshi 129:623-630.
53. Znaidi S, et al. 2008. Genome-wide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance. Eukaryot. Cell 7:836-847. (Pubitemid 351968827)